StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Sunday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $1.01 on Friday. The firm has a market cap of $78.67 million, a price-to-earnings ratio of -14.43 and a beta of 1.41. Milestone Scientific has a 52 week low of $0.54 and a 52 week high of $1.39. The firm’s 50-day simple moving average is $1.11 and its two-hundred day simple moving average is $0.96.

Institutional Investors Weigh In On Milestone Scientific

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MLSS. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the third quarter worth about $91,000. Renaissance Technologies LLC boosted its stake in Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific during the 3rd quarter valued at about $48,000. Geode Capital Management LLC increased its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares during the period. Finally, Carnegie Investment Counsel boosted its position in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after acquiring an additional 27,412 shares during the period. 5.79% of the stock is currently owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.